| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/15/2003 | EP1274852A2 Targeted vaccine delivery systems |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274711A1 New aza-indolyl derivatives |
| 01/15/2003 | EP1274710A2 Novel heteroaryl-diazabicycloalkanes |
| 01/15/2003 | EP1274709A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 01/15/2003 | EP1274707A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274697A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 01/15/2003 | EP1274694A1 Novel compounds |
| 01/15/2003 | EP1274686A1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274449A2 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 01/15/2003 | EP1274446A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 01/15/2003 | EP1274428A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274427A1 Formulation of substituted benzimidazoles |
| 01/15/2003 | EP1274415A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274414A1 Nasal administration of agents for the treatment of gastroparesis |
| 01/15/2003 | EP1274413A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274407A2 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 01/15/2003 | EP1274397A2 Drug delivery composition and device |
| 01/15/2003 | EP1274395A1 New formulations for the removal of dental plaque, tartar and dental stains |
| 01/15/2003 | EP1274322A1 Composition comprising free amino acids |
| 01/15/2003 | EP1274321A1 Use of polyphosphate as a tooth erosion inhibitor in acidic compositions |
| 01/15/2003 | EP1274319A2 Compositions and methods for improving vascular health |
| 01/15/2003 | EP1009524B1 Improvements in or relating to capsules |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
| 01/15/2003 | EP0649412B1 Pharmaceutical pyridine compounds |
| 01/15/2003 | EP0584347B1 Enantiomeric hydroxylated xanthine compounds |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391564A Chemical compounds |
| 01/15/2003 | CN1391556A IL-8 receptor antagonists |
| 01/15/2003 | CN1391482A Therapy |
| 01/15/2003 | CN1391478A Aqueous solution formulation of alpha-interferon |
| 01/15/2003 | CN1391475A Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1390832A N,N'-diacetylcystine-arginine salt and its preparing process and usage |
| 01/15/2003 | CN1390600A Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
| 01/15/2003 | CN1390598A Medicine made of lysimachia for treating hepatobiliary calculus and its prescription |
| 01/15/2003 | CN1390592A Powdered medicine for replenishing vital essence and beautifying face and its preparing process |
| 01/15/2003 | CN1390585A Chinese medicine for detoxication purpose and its preparing process |
| 01/15/2003 | CN1390583A Composite medicine for improving gastrointestinal function |
| 01/15/2003 | CN1390579A 'Weifukang' tablet for treating gastrosis |
| 01/15/2003 | CN1390577A Pill of tortoise plastron and turtle shell |
| 01/15/2003 | CN1390575A Medicine 'Yakang tea' for treating toothache |
| 01/15/2003 | CN1390567A Chinese medicine for treating icterohepatitis |
| 01/15/2003 | CN1390564A Medicine for treating digestive ulcer |
| 01/15/2003 | CN1390559A Mossback capsule and its preparing process |
| 01/15/2003 | CN1390558A Oral liquid made of mossback and its preparing process |
| 01/15/2003 | CN1390557A Mossback capsule for building up body and its preparing process |
| 01/15/2003 | CN1390552A Health-care mineral food and its preparing process |
| 01/15/2003 | CN1098703C Medical capsule for building up body and invigorating function of kidney |
| 01/15/2003 | CN1098699C Fushuixiao oral liquor (medicine for elimianting ascites) and preparing process |
| 01/15/2003 | CN1098697C Quick-acting powder preparation for curing toothache |
| 01/15/2003 | CN1098693C Chinese patent medicine for curing gastric ulcer |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/14/2003 | US6506816 Dental resin cement materials having unique handling properties are provided that comprise a) filler, b) polymerizable resin, and c) a polymeric handling modifier that is dispersed in the polymerizable resin at 25 degrees C. |
| 01/14/2003 | US6506802 Disulfide derivatives useful for treating allergic diseases |
| 01/14/2003 | US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and |
| 01/14/2003 | US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of |
| 01/14/2003 | US6506779 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 01/14/2003 | US6506775 Substituted benzylaminopiperidine compounds |
| 01/14/2003 | US6506774 The use of orexin receptor antagonists as neuroprotectants, and in the treatment of nausea and vomiting, irritable bowel syndrome and other conditions associated with visceral pain. |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506768 Tetrahydro γ-carbolines |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/14/2003 | US6506756 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 01/14/2003 | US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/14/2003 | US6506748 Aromatic heterocyclic compounds as antiinflammatory agents |
| 01/14/2003 | US6506740 Compounds that can be substituted at the 7, 8, and/or 9 positions and methods for preparing the 4- dedimethylamino tetracycline compounds. Other tetracycline compounds are the 4-dedimethylaminotetracycline derivatives with an oxime |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506574 Drug screening, liver replenishment; culturing with cellular differentiation agent |
| 01/14/2003 | US6506411 Anti-angiogenic compositions and methods of use |
| 01/14/2003 | US6506406 Reduces smell of feces |
| 01/14/2003 | US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies |
| 01/14/2003 | CA2114313C Bpc peptides, their preparation and use |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |
| 01/09/2003 | WO2003002567A1 New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
| 01/09/2003 | WO2003002566A1 Purine derivatives as a2b adenosine receptor antagonists |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002556A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002552A1 Novel indole derivatives |
| 01/09/2003 | WO2003002544A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002510A1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/09/2003 | WO2003002152A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | WO2003002147A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 01/09/2003 | WO2003002145A1 Diagnosis and treatment of insulin-dependent diabetes mellitus and insulitis |
| 01/09/2003 | WO2003002140A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |